Biochemical profile of anseculin (KA-672) at different brain receptors

Drug Development Research

Volumn 55, Issue 4, 2002, Pages 187-196

  Knauber, J ^a   Muller W E ^a,b  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ADENYLATE CYCLASE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANSECULIN; BRAIN RECEPTOR; BUSPIRONE; CARBACHOL; CLOZAPINE; CYCLIC AMP; DOXAZOSIN; FORSKOLIN; INOSITOL PHOSPHATE; NORADRENALIN; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; QUINUCLIDINYL BENZILATE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; YOHIMBINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DRUG ANTAGONISM; DRUG INDICATION; DRUG INHIBITION; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; IC 50; MOUSE; NONHUMAN;

EID: 0036062208     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10053     Document Type: Article

References (27)

1. A role for norepinephrine in stress-induced cognitive deficits: α-1-adrenoceptor mediation in the prefrontal cortex
2. 1A receptors negatively coupled with adenylate cyclase in hippocampal neurons
3. Treatment of Alzheimer's disease: Molecular pathology versus neurotransmitter-based therapy
4. Effects of KA-672 on some excitatory amino acid induced phenomena
5. Inhibition of Forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists
6. The role of norephinephrine in the pathophysiology of cognitive disorders: Potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease
7. Specific decrease of high-affinity agonist states of alpha-2-adrenoceptors in the aging mouse brain
8. Cholinergic therapy of Alzheimer's disease: From experimental hypothesis to clinical reality
9. Age-related changes in receptor-mediated and depolarization-induced phosphatidylinositol turnover in mouse brain
10. KA-672 inhibits rat brain acetylcholinesterase in vitro but not in vivo
11. 8-Hydroxy-(2-n-propyl-amino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT receptor stimulatory activity
12. Serotonin receptor sensitivity in major depression
13. KA-672-HCl: A new orally active antidementia agent
14. 1-receptor up-regulation
15. 1b-adrenoceptor
16. Radioligand binding studies of adrenergic receptors
17. The putative cognitive enhance KA-672.HCl is an uncompetitive voltage-dependent NMDA receptor antagonist
18. Local infusion of an α-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys
19. KA-672
20. Benzodiazepine hypnotics: Time course and potency of benzodiazepine receptor occupation after oral application
21. KA-672-HCl: A novel acetylcholinesterase inhibitor with no effects on arylacylamidase or butyrylcholinesterase
22. 1C binding sites in rat frontal cortex
23. Chronic treatment with piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged mice
24. KA 672-HCl, a neuronal activator against dementia: Tolerability, safety and preliminary pharmacokinetics after single and multiple oral doses in healthy male and female volunteers
25. Age-related deficits of central muscarinic cholinergic receptor function in the mouse: Partial restoration by chronic piracetam treatment
26. The noradrenergic system in pathological anxiety: A focus on panic with relevance to generalized anxiety and phobias
27. 1A component